BIOCRYST PHARMACEUTICALS, INC. Inventory Adjustments
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Inventory Adjustments of $170.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Inventory › Inventory, Net
us-gaap:InventoryAdjustments · last filed 2023-11-08
- 2023-09-30: Inventory Adjustments $170.00K.
- 2023-06-30: Inventory Adjustments $238.00K.
- 2023-03-31: Inventory Adjustments $236.00K.
- 2022-12-31: Inventory Adjustments $932.00K.
| Period end | Inventory Adjustments |
|---|---|
| 2023-09-30 | $170.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $238.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $236.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $932.00K 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |